Osteoarthritis

RCT data backs supplement for joint pain benefits

RCT data backs supplement for joint pain benefits

By Nathan Gray

A commercial dietary supplement marketed for joint pain has been backed to alleviate joint pain severity and reduce dificulties in performing day to day tasks, according to a new study.

EFSA rejects Merck glucosamine-joint health appeal

EFSA rejects Merck glucosamine-joint health appeal

By Shane Starling

The European Food Safety Authority (EFSA) says German drug giant Merck has failed to convince it that glucosamine can benefit joint health and will not be changing its earlier rejection of the claim.

EFSA rejects Merck glucosamine-joint health claim

EFSA health claim opinion

EFSA rejects Merck glucosamine-joint health claim

Glucosamine does not help maintain normal joint cartilage, the European Food Safety Authority (EFSA) has found after assessing a proprietary article 13.5 dossier submitted by drug giant, Merck Consumer Healthcare.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers